First quarter 2021 results presentation

Operating income, growth figures, profitability and how our products have behaved.


No votes yet
 
Related
​The new facility has meant an investment of 11 million euros This new line, which has now been authorised to commence commercial...
3 min
20/06/2024
Operating revenue was 151.2 million euros in the first quarter of 2024, a 25% decrease on the first quarter of 2023, mainly due...
4 min
08/05/2024
Agreement to manufacture pre-filled syringes for a global pharmaceutical company Production will take place on one state-of-the-art...
3 min
25/04/2024